Trial Profile
conversion From the twice-daily to the once-daily tacrolimus formulation does not reduce intra-patient variability in tacrolimus exposure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 22 Dec 2015 New trial record